O2C
The computed 12-month bankruptcy probability of O2C is 0.6% (low). The company has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 14 yrs |
| Board | 1 |
| Locations | 1 |
| Publications | 2 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | micro | 22-08-2025 | 2025-00406002 |
| 31-12-2023 | micro | 01-10-2024 | 2024-00484144 |
| 31-12-2022 | micro | 07-08-2023 | 2023-00322092 |
| 31-12-2021 | micro | 07-10-2022 | 2022-20457631 |
| 31-12-2020 | micro | 31-08-2021 | 2021-64600413 |
| 31-12-2019 | micro | 05-10-2020 | 2020-59000348 |
| 31-12-2018 | micro | 30-08-2019 | 2019-61100015 |
| 31-12-2017 | micro | 31-08-2018 | 2018-58700066 |
| 31-12-2016 | micro | 06-07-2017 | 2017-28500077 |
| 31-12-2015 | volledig | 26-07-2016 | 2016-35800004 |
-
OLBRECHTS, Olivier Ivan ValéryDirectorState Gazette act 24314782 (09-01-2024)Current09-01-2024 → present
| NACE primary | 82990 |
| Legal form | Private limited company(610) |
| Incorporation | 29-03-2012 |
| Status | Active |
| Postal code | 1180 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21614H0008/00F051 | Brussels | 832 m² | 1 · 175 m² | 10.4 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
31-03-2026 Act object · Board meeting · Officer resignation · Officer appointment
- Filing: 2026-03-24 · PharmaBXL
- Act object: Ontslag en benoeming gedelegeerd bestuurder · PharmaBXL
- Board meeting: 2026-02-13 · PharmaBXL
- Officer resignation: role: gedelegeerd bestuurder, effective_date: 2026-02-13 · O2C
- Officer appointment: role: gedelegeerd bestuurder, duration: onbepaalde duur, effective_date: 2026-02-13 · PharmaLegal
- Publication: 2026-03-31
Technical details
{
"facts": [
{
"type": "filing",
"quote": "24 MAART 2026 ter griffie van de Nederlandstalige ondernemingsrechtbank Brussel",
"value": "2026-03-24",
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Onderwerp akte: Ontslag en benoeming gedelegeerd bestuurder",
"value": "Ontslag en benoeming gedelegeerd bestuurder",
"object": null,
"subject": "e1"
},
{
"type": "board_meeting",
"quote": "Uittreksel uit de notulen van de vergadering van de raad van bestuur gehouden op 13/02/2026:",
"value": "2026-02-13",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "De raad van bestuur besluit om de besloten vennootschap \u0022O2C\u0022 (ondernemingsnummer 0844.823.280), vast vertegenwoordigd door de heer Olivier OLBRECHTS, met ingang van heden te ontslaan als gedelegeerd bestuurder.",
"value": {
"role": "gedelegeerd bestuurder",
"effective_date": "2026-02-13"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_appointment",
"quote": "Vervolgens besluit de raad van bestuur om - overeenkomstig artikel 11 \u00A71 van de statuten - het dagelijks bestuur van de vennootschap te delegeren aan de volgende bestuurder, die bijgevolg wordt aangesteld als gedelegeerd bestuurder: De besloten vennootschap \u0022PharmaLegal\u0022... Dit mandaat neemt ingang op heden en wordt toegekend voor onbepaalde duur.",
"value": {
"role": "gedelegeerd bestuurder",
"duration": "onbepaalde duur",
"effective_date": "2026-02-13"
},
"object": "e1",
"subject": "e4"
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 31/03/2026",
"value": "2026-03-31",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1850,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0795.508.480",
"kind": "company",
"name": "PharmaBXL",
"attrs": {
"seat": "Koekelberglaan 1, 1082 Sint-Agatha-Berchem",
"legal_form": "Besloten vennootschap"
}
},
{
"id": "e2",
"kbo": "0844.823.280",
"kind": "company",
"name": "O2C",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Olivier OLBRECHTS",
"attrs": {
"role": "vast vertegenwoordiger van O2C"
}
},
{
"id": "e4",
"kbo": "0541.432.719",
"kind": "company",
"name": "PharmaLegal",
"attrs": {
"rpr": "RPR Brussel (Nederlandstalige afdeling)",
"seat": "Besmelaan 103, 1190 Vorst",
"legal_form": "Besloten vennootschap"
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Georges DE FEU",
"attrs": {
"role": "vaste vertegenwoordiger van PharmaLegal"
}
}
]
}09-01-2024 OLBRECHTS, Olivier Ivan Valéry appointed as director
- OLBRECHTS, Olivier Ivan Valéry, Bestuurder
Technical details
{
"events": [
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "OLBRECHTS, Olivier Ivan Val\u00E9ry",
"address": "1180 Uccle, Avenue du Prince d\u0027Orange 50",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cidera \u00E0 la prochaine assembl\u00E9e g\u00E9n\u00E9rale annuelle sur la d\u00E9charge au g\u00E9rant d\u00E9missionnaire pour l\u2019ex\u00E9cution de son mandat.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "OLBRECHTS, Olivier Ivan Val\u00E9ry",
"address": "1180 Uccle, Avenue du Prince d\u0027Orange 50",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": "niet_statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de mettre fin \u00E0 la fonction du g\u00E9rant actuel, mentionn\u00E9 ci-apr\u00E8s, et proc\u00E8de imm\u00E9diatement au renouvellement de sa nomination comme administrateur non statutaire pour une dur\u00E9e illimit\u00E9e",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "H\u00E9l\u00E8ne Desenfans",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-01-09",
"filing_date": "2024-01-04",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-12-26",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0844.823.280",
"name_full": "O2C",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019acte",
"coordination des statuts",
"rapport de l\u2019administrateur"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | O2C |